In patients with poor glycemic control (aBG > 180 mg/dL), the mortality risk was higher than in those without diabetes but did not reach statistical significance after adjustment (unadjusted HR: 1.95 [1.19–3.20]; p = 0.008; adjusted HR: 1.58 [0.95–2.65]; p = 0.080).
← all excerpts
Impact of diabetes and glycemic control during cancer care on mortality in non-metastatic solid and hematologic malignancies.
1
0.0080
0.0080